Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype

Triple-negative breast cancer (TNBC) is an aggressive malignancy characterized by the lack of expression of estrogen and progesterone receptors and amplification of human epidermal growth factor receptor 2 (HER2). Being the Epidermal Growth Factor Receptor (EGFR) highly expressed in mesenchymal TNBC...

Descripción completa

Detalles Bibliográficos
Autores principales: Nisticò, Nancy, Aloisio, Annamaria, Lupia, Antonio, Zimbo, Anna Maria, Mimmi, Selena, Maisano, Domenico, Russo, Rossella, Marino, Fabiola, Scalise, Mariangela, Chiarella, Emanuela, Mancuso, Teresa, Fiume, Giuseppe, Omodei, Daniela, Zannetti, Antonella, Salvatore, Giuliana, Quinto, Ileana, Iaccino, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093212/
https://www.ncbi.nlm.nih.gov/pubmed/37048151
http://dx.doi.org/10.3390/cells12071078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093212/
https://www.ncbi.nlm.nih.gov/pubmed/37048151
http://dx.doi.org/10.3390/cells12071078

Ejemplares similares